FDCDDQ
VRNA

Federation des caisses Desjardins du Quebec’s Verona Pharma VRNA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-210
Closed -$22.4K – 3011
2025
Q3 		$22.4K Hold
210
– – ﹤0.01% 2020
2025
Q2 		$19.9K Hold
210
– – ﹤0.01% 1817
2025
Q1 		$13.3K Sell
210
-55
-21% -$3.29K ﹤0.01% 1862
2024
Q4 		$12.3K Hold
265
– – ﹤0.01% 1809
2024
Q3 		$7.62K Sell
265
-135
-34% -$3.32K ﹤0.01% 1972
2024
Q2 		$5.78K Hold
400
– – ﹤0.01% 1933
2024
Q1 		$6.44K Hold
400
– – ﹤0.01% 1906
2023
Q4 		$7.95K Hold
400
– – ﹤0.01% 1802
2023
Q3 		$6.52K Hold
400
– – ﹤0.01% 1851
2023
Q2 		$8.46K Hold
400
– – ﹤0.01% 1807
2023
Q1 		$8.03K Hold
400
– – ﹤0.01% 1816
2022
Q4 		$10.5K Sell
400
-250
-38% -$3.33K ﹤0.01% 1866
2022
Q3 		$6.64K Hold
650
– – ﹤0.01% 2012
2022
Q2 		$2.72K Hold
650
– – ﹤0.01% 2259
2022
Q1 		$3.24K Buy
+650
New +$3.78K ﹤0.01% 2291

Other funds holding VRNA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's VRNA Position: Q4 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 210 shares — an estimated $22.4K sold.

Federation des caisses Desjardins du Quebec first reported a position in VRNA in Q1 2022 and held it in 15 quarters. The position peaked at $22.4K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 210 Verona Pharma shares in Q4 2025, an estimated $22.4K.
  • Federation des caisses Desjardins du Quebec first reported a position in Verona Pharma in Q1 2022 and held it in 15 quarters.
  • Federation des caisses Desjardins du Quebec's Verona Pharma position peaked at $22.4K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2025, filed 12 Feb 2026.